Leveraging artificial intelligence and deep learning, CureMetrix develops medical image analysis tools to improve early disease detection and patient outcomes — with a particular focus on women’s health and mammography. Our goal is to equip radiologists with objective, data-driven answers that support earlier, more accurate diagnoses and reduced healthcare costs.

We build adjunct AI products for radiology (including cmAssist®, cmTriage®, cmDensity™, and cmAngio®) designed to integrate into existing clinical workflows. Our platform is trained and validated on millions of images to reduce false positives, improve evaluation of dense breast tissue, and help track treatment response over time.

CureMetrix partners with practicing clinicians and institutions globally to deliver clinically effective, easy-to-deploy solutions that increase screening confidence and efficiency. We pursue rigorous research, regulatory compliance, and continual validation to maximize clinical benefit and support better outcomes for patients and providers.